PubMed=11987130; DOI=10.1002/1615-9861(200205)2:5<561::AID-PROT561>3.0.CO;2-K
Lichtenfels R., Kellner R., Bukur J.H., Beck J., Brenner W., Ackermann A., Seliger B.
Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma.
Proteomics 2:561-570(2002)

CLPUB00420
Bukur J.H.
Characterization of T cell responses against human renal cell carcinoma and identification of HLA-G as a tumor-associated antigen and immune evasion mechanism of renal cell carcinoma.
Thesis PhD (2004); Johannes Gutenberg University Mainz; Mainz; Germany

PubMed=17200335; DOI=10.1158/1078-0432.CCR-06-0824
Seliger B., Fedorushchenko A., Brenner W., Ackermann A., Atkins D., Hanash S.M., Lichtenfels R.
Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration.
Clin. Cancer Res. 13:27-37(2007)

PubMed=21595034; DOI=10.1002/pmic.201000486; PMCID=PMC3517181
Seliger B., Dressler S.P., Massa C., Recktenwald C.V., Altenberend F., Bukur J.H., Marincola F.M., Wang E., Stevanovic S., Lichtenfels R.
Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells.
Proteomics 11:2528-2541(2011)

PubMed=23696916; PMCID=PMC3657351
Stoehr C.G., Buettner-Herold M., Kamphausen E., Bertz S., Hartmann A., Seliger B.
Comparative expression profiling for human endoplasmic reticulum-resident aminopeptidases 1 and 2 in normal kidney versus distinct renal cell carcinoma subtypes.
Int. J. Clin. Exp. Pathol. 6:998-1008(2013)